## AIG: American International Group, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.5% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($83.05)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Ethic Inc. Sells 12,854 Shares of American International Group, Inc. $AIG**
- Source: MarketBeat | 20251230T090731 | Neutral | Relevance: 100%
- Ethic Inc. reduced its stake in American International Group (NYSE:AIG) by 10.1% in the third quarter, selling 12,854 shares and now holding 114,014 shares valued at $8.96 million. The insurance provider reported quarterly EPS of $2.20, surpassing analyst estimates, although revenue missed expectations. AIG also announced a quarterly dividend of $0.45 per share, resulting in an annualized dividend of $1.80 and a yield of approximately 2.1%.

**2. Pacer Advisors Inc. Has $5.05 Million Position in MetLife, Inc. $MET**
- Source: MarketBeat | 20251230T111219 | Somewhat-Bullish | Relevance: 65%
- Pacer Advisors Inc. increased its stake in MetLife, Inc. (NYSE:MET) by 31.2% in the third quarter, now holding 61,306 shares valued at $5.05 million. Institutional investors collectively own 94.99% of the company, with significant recent acquisitions by Norges Bank, ABN AMRO Bank N.V., Amundi, and Man Group plc. Analysts maintain a consensus "Buy" rating for MetLife with a target price of $95.73.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Piper Sandler | $95 | $88 | +8% |
| 2025-12-16 | TD Cowen | $90 | $86 | +5% |
| 2025-12-16 | Mizuho | $84 | $0 | 0% |
| 2025-12-05 | Barclays | $88 | $95 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Piper Sandler | main | Overweight |
| 2025-12-16 | TD Cowen | main | Hold |
| 2025-12-16 | Mizuho | init | Neutral |
| 2025-12-05 | Barclays | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 5 ($1017.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+11.6%)
- Blackrock Inc.: 8.7% (-1.7%)
- Capital Research Glo: 5.3% (+79.6%)
- Wellington Managemen: 4.8% (+7.9%)
- State Street Corpora: 4.7% (-3.2%)

### Key Risks

1. Heavy insider selling: $1018M sold (5 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.85 indicates undervaluation relative to growth. Forward P/E 10.9x attractive for 13% earnings growth. Balance sheet: strong liquidity (9.6x). Analyst sentiment positive (2 raises, avg +6%). Insider selling cluster ($1018.0M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $47.7B |
| Beta | 0.63 |
| 52W Range | $69.24 - $88.07 |
| Short Interest | 3.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.85 |
| Forward P/E | 10.9 |
| Current P/E | 12.4 |
| YoY Growth | 13.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 0.6% to -0.5% (-1.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.5pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.1%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.46% (CS: 47) | Neutral |
| RSI_14 | 69.3 | Neutral |
| MACD Histogram | 0.20 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.082x | Above |
| vs SMA200 | 1.061x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $86.13
- **Stop Loss:** $83.05 (3.6% risk)
- **Target:** $89.21 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 267
- **Position Value:** $22,996.71
- **Portfolio %:** 23.00%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-10 (Est: $1.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.71 | $2.20 | +28.5% |
| 2025Q2 | $1.60 | $1.81 | +13.2% |
| 2025Q1 | $0.99 | $1.17 | +17.6% |
| 2024Q4 | $1.23 | $1.30 | +6.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*